Cumberland Partners LTD Eli Lilly & CO Transaction History

Cumberland Partners LTD

$1.26 Billion
Q2 2024

A detailed history of Cumberland Partners LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Cumberland Partners LTD holds 8,042 shares of LLY stock, worth $7.06 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

8,042

Previous 6,832 17.71%

Holding current value

$7.06 Million

Previous $5.32 Million 36.99%

% of portfolio

0.58%

Previous 0.42%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $877,092 - $1.1 Million	1,210 Added 17.71%	8,042 $7.28 Million
Q1 2024 May 09, 2024	SELL	$592.2 - $792.28 $706,494 - $945,190	-1,193 Reduced 14.87%	6,832 $5.32 Million
Q4 2023 Feb 01, 2024	SELL	$525.19 - $619.13 $2.22 Million - $2.61 Million	-4,220 Reduced 34.46%	8,025 $4.68 Million
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $120,846 - $166,605	-278 Reduced 2.22%	12,245 $6.58 Million
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $2.48 Million - $3.32 Million	7,070 Added 129.65%	12,523 $5.87 Million
Q1 2023 May 08, 2023	SELL	$310.63 - $364.82 $4.36 Million - $5.13 Million	-14,050 Reduced 72.04%	5,453 $1.87 Million
Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $1.14 Million - $1.32 Million	-3,530 Reduced 15.33%	19,503 $7.13 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $592,960 - $675,740	2,000 Added 9.51%	23,033 $7.45 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $90,587 - $106,362	325 Added 1.57%	21,033 $6.82 Million
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $2.84 Million - $3.53 Million	12,115 Added 140.99%	20,708 $5.93 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $1.93 Million - $2.4 Million	8,593 New	8,593 $2.37 Million
Q1 2021 May 11, 2021	SELL	$164.32 - $212.72 $1.24 Million - $1.6 Million	-7,545 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $293,535 - $388,417	2,250 Added 42.49%	7,545 $1.27 Million
Q3 2020 Nov 03, 2020	BUY	$146.22 - $169.13 $774,234 - $895,543	5,295 New	5,295 $784,000
Q2 2020 Aug 04, 2020	SELL	$136.42 - $164.18 $748,945 - $901,348	-5,490 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $226,195 - $279,965	-1,900 Reduced 25.71%	5,490 $762,000
Q4 2019 Feb 07, 2020	SELL	$106.92 - $132.43 $6,949 - $8,607	-65 Reduced 0.87%	7,390 $971,000
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $199,163 - $216,638	1,865 Added 33.36%	7,455 $834,000
Q2 2019 Aug 08, 2019	SELL	$110.79 - $129.32 $62,263 - $72,677	-562 Reduced 9.14%	5,590 $619,000
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $148,264 - $174,518	1,332 Added 27.63%	6,152 $798,000
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $97,428 - $109,148	920 Added 23.59%	4,820 $558,000
Q2 2018 Aug 09, 2018	BUY	$75.7 - $86.88 $295,230 - $338,832	3,900 New	3,900 $333,000

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cumberland Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Cumberland Partners LTD with notifications on news.

Account

Cumberland Partners LTD Eli Lilly & CO Transaction History